Arrivent Biopharma Inc
NASDAQ:AVBP
Profitability Summary
Arrivent Biopharma Inc's profitability score is 20/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
Score
Margins
Earnings Waterfall
Arrivent Biopharma Inc
Margins Comparison
Arrivent Biopharma Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| US |
A
|
Arrivent Biopharma Inc
NASDAQ:AVBP
|
970.5m USD |
Loading...
|
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
236.5B USD |
Loading...
|
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
Loading...
|
|
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
94.2B ZAR |
Loading...
|
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
71B USD |
Loading...
|
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
59.9B USD |
Loading...
|
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
33.3B CHF |
Loading...
|
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
40.5B USD |
Loading...
|
Loading...
|
|
| US |
|
Halliburton Co
NYSE:HAL
|
30.8B USD |
Loading...
|
Loading...
|
|
| US |
|
Symbotic Inc
NASDAQ:SYM
|
30.9B USD |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Arrivent Biopharma Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Arrivent Biopharma Inc
NASDAQ:AVBP
|
970.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
236.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
94.2B ZAR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
71B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
59.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
33.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Halliburton Co
NYSE:HAL
|
30.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Symbotic Inc
NASDAQ:SYM
|
30.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
